Display options
Share it on

BMC Public Health. 2013 Jun 20;13:599. doi: 10.1186/1471-2458-13-599.

Prevalence of metabolic syndrome among urban community residents in China.

BMC public health

Guang-Rong Wang, Li Li, Yi-Hui Pan, Guo-Dong Tian, Wan-Long Lin, Zhe Li, Zheng-Yi Chen, You-Long Gong, George E Kikano, Kurt C Stange, Ke-Liang Ni, Nathan A Berger

Affiliations

  1. Zhabei District Health Bureau, Shanghai, People's Republic of China.

PMID: 23786855 PMCID: PMC3734094 DOI: 10.1186/1471-2458-13-599

Abstract

BACKGROUND: Metabolic risk factors and abnormalities such as obesity and hypertension are rapidly rising among the Chinese population following China's tremendous economic growth and widespread westernization of lifestyle in recent decades. Limited information is available about the current burden of metabolic syndrome (MetS) in China.

METHODS: We analyzed data on metabolic risk factors among 22,457 adults aged ≥ 32 years participating in the "Zhabei Health 2020" survey (2009-2010), a cross-sectional study of a representative sample of community residents in Zhabei District. We defined MetS using Chinese-specific cut-off points for central obesity according to consensus criteria recently endorsed by several international and national organizations in defining MetS in different populations worldwide. We used a multiple logistic regression model to assess the associations of potential risk factors with MetS.

RESULTS: The unadjusted prevalence of the MetS was 35.1% for men and 32.5% for women according to the consensus criteria for Chinese. The prevalence increased progressively from 12.1% among participants aged 32-45 years to 45.4% among those aged ≥ 75 years. Age, smoking, family history of diabetes, and education are significantly associated with risk of MetS.

CONCLUSIONS: The MetS is highly prevalent and has reached epidemic proportion in Chinese urban adult community residents.

References

  1. Circulation. 2002 Dec 17;106(25):3143-421 - PubMed
  2. Am J Clin Nutr. 2004 Jan;79(1):31-9 - PubMed
  3. BMC Public Health. 2010 May 12;10:246 - PubMed
  4. Diabetes Care. 2005 Jul;28(7):1769-78 - PubMed
  5. Lancet. 2005 Sep 24-30;366(9491):1059-62 - PubMed
  6. Diabetes Care. 2005 Nov;28(11):2745-9 - PubMed
  7. Am J Cardiol. 1999 May 13;83(9B):25F-29F - PubMed
  8. Eur J Clin Nutr. 1999 Jun;53(6):468-72 - PubMed
  9. Metab Syndr Relat Disord. 2009 Feb;7(1):37-45 - PubMed
  10. Asia Pac J Clin Nutr. 2010;19(1):98-102 - PubMed
  11. N Engl J Med. 2002 Feb 7;346(6):393-403 - PubMed
  12. Lancet. 2005 Apr 16-22;365(9468):1398-405 - PubMed
  13. N Engl J Med. 2001 Sep 13;345(11):790-7 - PubMed
  14. Circulation. 2009 Oct 20;120(16):1640-5 - PubMed
  15. Circulation. 2004 Jan 27;109(3):433-8 - PubMed
  16. N Engl J Med. 2001 May 3;344(18):1343-50 - PubMed
  17. Int J Obes Relat Metab Disord. 2003 Feb;27(2):253-9 - PubMed
  18. JAMA. 2002 Dec 4;288(21):2709-16 - PubMed
  19. N Engl J Med. 2010 Mar 25;362(12):1090-101 - PubMed
  20. Asia Pac J Clin Nutr. 2008;17 Suppl 1:37-42 - PubMed
  21. Int J Obes Relat Metab Disord. 1999 May;23(5):537-42 - PubMed
  22. JAMA. 2001 May 16;285(19):2486-97 - PubMed
  23. Nutr Metab Cardiovasc Dis. 2005 Aug;15(4):250-4 - PubMed
  24. Biomed Environ Sci. 2001 Jun;14(1-2):53-60 - PubMed
  25. Circulation. 2005 Oct 25;112(17):2735-52 - PubMed
  26. Q J Med. 1991 Dec;81(296):1021-30 - PubMed
  27. Am J Clin Nutr. 2006 Aug;84(2):289-98 - PubMed

MeSH terms

Publication Types